华人网

标题: Global Hyaluronic Acid (Sodium +Injection) （透明质酸（钠+注射液））Sales Mar... [打印本页]

作者: 恒州博智 时间: 2018-9-19 17:38
标题: Global Hyaluronic Acid (Sodium +Injection) （透明质酸（钠+注射液））Sales Mar...

本文为QYResearch分析师整理首发，若转载请写明来源

发布者：QYR

This report studies the global Hyaluronic Acid (Sodium +Injection) market status and forecast, categorizes the global Hyaluronic Acid (Sodium +Injection) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Hyaluronic acid (HA) is a naturally occurring polymer found throughout the body. HA is vital for maintaining the function of healthy tissue, and can be used for a variety of applications.

In the last several years, Global market of Hyaluronic Acid (Sodium +Injection) developed rapidly, with an average growth rate of 23%. In 2015, Global capacity of Hyaluronic Acid (Sodium +Injection) is nearly12800 k pieces; the actual production is about 11000 k pieces.

Europe region is the largest supplier of Hyaluronic Acid (Sodium +Injection), with a production market share nearly 38%. United States is the second largest supplier of Hyaluronic Acid (Sodium +Injection), enjoying production market share nearly 29%.

North America is the largest consumption place, with a consumption market share nearly 34.5%. Following North America, Europe is the second largest consumption place with the consumption market share of 29.3%.

Market competition is not intense. Corneal (Allergan), Galdermal (Q-Med), LG Life Science, and Bohus BioTechetc, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

With the development of medical technology level, more and more companies participate in this industry. The use in Beauty industry will be more and more.

The global Hyaluronic Acid (Sodium +Injection) market is valued at 3850 million US$ in 2017 and will reach 14700 million US$ by the end of 2025, growing at a CAGR of 18.2% during 2018-2025.

The major players covered in this report

Corneal(Allergan)

Galdermal(Q-Med)

LG Life Science

Bohus BioTech

IMEIK

Bloomage Freda

...

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

United States

Europe

China

Japan

Southeast Asia

India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Hyaluronic Acid Injection

Hyaluronic Acid Sodium

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Beauty Industry

Therapy

欢迎光临华人网 (https://kr.chineseol.com/)